Screener
PILL vs HIBS
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF vs Direxion Daily S&P 500 High Beta Bear 3X Shares
Key differences
- PILL costs 0.08% less per year.
- PILL follows a leveraged strategy; HIBS uses inverse.
- Over the last 3 years, PILL has delivered higher annualized returns.
Side-by-side comparison
| PILL | HIBS | |
|---|---|---|
| Annual cost (TER) | 0.98% | 1.06% |
| Fund size (AUM) | $13M | $19M |
| Since | 2017 | 2019 |
| Dividend yield | 0.63% | 7.92% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | inverse |
| CAGR 1Y | +146.6% | -80.6% |
| CAGR 3Y | +15.6% | -62.8% |
| CAGR 5Y | -9.3% | -52.3% |
| Sharpe 3Y | 0.48 | -0.97 |
| Volatility 1Y | 61.07% | 67.54% |
| Max drawdown | -88.76% | -99.98% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PILL and HIBS
Explore further